FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2907115174> ?p ?o ?g. }

• W2907115174 endingPage "767" @default.
• W2907115174 startingPage "756" @default.
• W2907115174 abstract "Particle size distribution and stability are key attributes for the evaluation of the safety and efficacy profile of medical nanoparticles (Med-NPs). Measuring particle average size and particle size distribution is a challenging task which requires the combination of orthogonal high-resolution sizing techniques, especially in complex biological media. Unfortunately, despite its limitations, due to its accessibility, low cost, and easy handling, batch mode dynamic light scattering (DLS) is still very often used as the only approach to measure particle size distribution in the nanomedicine field. In this work the use of asymmetric flow field flow fractionation coupled to multiangle light scattering and dynamic light scattering detectors (AF4-MALS-DLS) was evaluated as an alternative to batch mode DLS to measure the physical properties of lipid-based nanoparticles. A robust standard operating procedure (SOPs) developed by the Nanomedicine Characterization Laboratory (EUNCL) was presented and tested to assess size stability, batch to batch consistency, and the behavior of the lipid-based nanoparticles in plasma. Orthogonal sizing techniques, such as transmission electron microscopy (TEM) and particle tracking analysis (PTA) measurements, were performed to support the results. While batch mode DLS could be applied as a fast and simple method to provide a preliminary insight into the integrity and polydispersity of samples, it was unsuitable to resolve small modifications of the particle size distribution. The introduction of nanoparticle sorting by field-flow fractionation coupled to online DLS and MALS allowed assessment of batch to batch variability and changes in the size of the lipid nanoparticles induced by the interaction with serum proteins, which are critical for quality control and regulatory aspects. In conclusion, if a robust SOP is followed, AF4-MALS-DLS is a powerful method for the preclinical characterization of lipid-based nanoparticles." @default.
• W2907115174 created "2019-01-11" @default.
• W2907115174 creator A5023453567 @default.
• W2907115174 creator A5030283020 @default.
• W2907115174 creator A5052066908 @default.
• W2907115174 creator A5053566805 @default.
• W2907115174 creator A5058781354 @default.
• W2907115174 creator A5063801352 @default.
• W2907115174 creator A5072385165 @default.
• W2907115174 creator A5079396522 @default.
• W2907115174 date "2019-01-03" @default.
• W2907115174 modified "2023-10-12" @default.
• W2907115174 title "Measuring Particle Size Distribution by Asymmetric Flow Field Flow Fractionation: A Powerful Method for the Preclinical Characterization of Lipid-Based Nanoparticles" @default.
• W2907115174 cites W1863721125 @default.
• W2907115174 cites W1974900416 @default.
• W2907115174 cites W1975227215 @default.
• W2907115174 cites W1990726512 @default.
• W2907115174 cites W2024821921 @default.
• W2907115174 cites W2031164044 @default.
• W2907115174 cites W2034082246 @default.
• W2907115174 cites W2049911716 @default.
• W2907115174 cites W2054745605 @default.
• W2907115174 cites W2063318887 @default.
• W2907115174 cites W2065127913 @default.
• W2907115174 cites W2070166910 @default.
• W2907115174 cites W2087999971 @default.
• W2907115174 cites W2090256391 @default.
• W2907115174 cites W2154181394 @default.
• W2907115174 cites W2194502287 @default.
• W2907115174 cites W2205710283 @default.
• W2907115174 cites W2228504944 @default.
• W2907115174 cites W2268101927 @default.
• W2907115174 cites W2319623974 @default.
• W2907115174 cites W2327273254 @default.
• W2907115174 cites W2415167501 @default.
• W2907115174 cites W2462667051 @default.
• W2907115174 cites W2469538125 @default.
• W2907115174 cites W2489891688 @default.
• W2907115174 cites W2581621989 @default.
• W2907115174 cites W2598883596 @default.
• W2907115174 cites W2606017739 @default.
• W2907115174 cites W2619656879 @default.
• W2907115174 cites W2625514655 @default.
• W2907115174 cites W2756327927 @default.
• W2907115174 cites W2769649361 @default.
• W2907115174 cites W2792625060 @default.
• W2907115174 cites W2794401570 @default.
• W2907115174 cites W2809369491 @default.
• W2907115174 cites W2897350207 @default.
• W2907115174 cites W4238682877 @default.
• W2907115174 cites W4256092651 @default.
• W2907115174 doi "https://doi.org/10.1021/acs.molpharmaceut.8b01033" @default.
• W2907115174 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6377179" @default.
• W2907115174 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30604620" @default.
• W2907115174 hasPublicationYear "2019" @default.
• W2907115174 type Work @default.
• W2907115174 sameAs 2907115174 @default.
• W2907115174 citedByCount "55" @default.
• W2907115174 countsByYear W29071151742019 @default.
• W2907115174 countsByYear W29071151742020 @default.
• W2907115174 countsByYear W29071151742021 @default.
• W2907115174 countsByYear W29071151742022 @default.
• W2907115174 countsByYear W29071151742023 @default.
• W2907115174 crossrefType "journal-article" @default.
• W2907115174 hasAuthorship W2907115174A5023453567 @default.
• W2907115174 hasAuthorship W2907115174A5030283020 @default.
• W2907115174 hasAuthorship W2907115174A5052066908 @default.
• W2907115174 hasAuthorship W2907115174A5053566805 @default.
• W2907115174 hasAuthorship W2907115174A5058781354 @default.
• W2907115174 hasAuthorship W2907115174A5063801352 @default.
• W2907115174 hasAuthorship W2907115174A5072385165 @default.
• W2907115174 hasAuthorship W2907115174A5079396522 @default.
• W2907115174 hasBestOaLocation W29071151741 @default.
• W2907115174 hasConcept C104317684 @default.
• W2907115174 hasConcept C111368507 @default.
• W2907115174 hasConcept C11432220 @default.
• W2907115174 hasConcept C120456961 @default.
• W2907115174 hasConcept C120665830 @default.
• W2907115174 hasConcept C121332964 @default.
• W2907115174 hasConcept C127313418 @default.
• W2907115174 hasConcept C145059251 @default.
• W2907115174 hasConcept C14631669 @default.
• W2907115174 hasConcept C147789679 @default.
• W2907115174 hasConcept C15083742 @default.
• W2907115174 hasConcept C155672457 @default.
• W2907115174 hasConcept C16031182 @default.
• W2907115174 hasConcept C171250308 @default.
• W2907115174 hasConcept C178790620 @default.
• W2907115174 hasConcept C185592680 @default.
• W2907115174 hasConcept C186060115 @default.
• W2907115174 hasConcept C187530423 @default.
• W2907115174 hasConcept C188027245 @default.
• W2907115174 hasConcept C191486275 @default.
• W2907115174 hasConcept C192562407 @default.
• W2907115174 hasConcept C20518536 @default.
• W2907115174 hasConcept C2777767291 @default.
• W2907115174 hasConcept C2778120352 @default.
• W2907115174 hasConcept C2778517922 @default.

• next